Cargando…

Culture of circulating tumor cells using a microfilter device

Circulating tumor cells (CTCs) are associated with cancer metastasis and prognosis but their scarcity in whole blood prevents their use as a diagnostic tool. The purpose of the present study was to establish a novel approach to capture and cultivate CTCs using a microfilter device. The present study...

Descripción completa

Detalles Bibliográficos
Autores principales: Furukawa, Atsuko, Mori, Tomoko, Shimomura, Osamu, Araki, Kazuhisa, Oda, Tatsuya, Matsusaka, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091075/
https://www.ncbi.nlm.nih.gov/pubmed/36999627
http://dx.doi.org/10.3892/or.2023.8538
Descripción
Sumario:Circulating tumor cells (CTCs) are associated with cancer metastasis and prognosis but their scarcity in whole blood prevents their use as a diagnostic tool. The purpose of the present study was to establish a novel approach to capture and cultivate CTCs using a microfilter device. The present study was a prospective study of patients with pancreatic cancer at the University of Tsukuba Hospital (Tsukuba, Japan). From each patient, 5 ml of whole blood was collected into an EDTA collection tube. Whole blood was filtered to isolate CTCs and cells captured on the microfilter were cultured in place. A total of 15 patients were enrolled. CTCs and/or CTC clusters were detected in 2 of 6 cases on day 0. In all cases, CTCs and/or formed clusters and/or colonies were observed during long-term culture periods of up to 103 days. In samples where CTCs were not immediately evident, CTC clusters and colonies emerged after long-term culture. To confirm activity of the cultured CTCs on the filters, staining with Calcein AM was performed and epithelial cellular adhesion molecule-positive cells were observed. The system enables the capture and culture of CTCs. Cultured CTCs may be used for patient-specific drug susceptibility testing and genomic profiling of cancer.